Aug 6, 2026 08:22AM
Aug 6, 2026 08:00AM
May 7, 2026 08:03AM
May 7, 2026 08:00AM
Feb 26, 2026 06:06AM
Feb 26, 2026 06:00AM
Feb 19, 2026 06:00AM Aurinia Pharmaceuticals to Report Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provide Update on Recent Business Progress on February 26, 2026
Nov 4, 2025 06:01AM
Nov 4, 2025 06:00AM
Nov 3, 2025 06:00AM
Jul 31, 2025 06:03AM
Jul 31, 2025 06:00AM
May 12, 2025 06:08AM
May 12, 2025 06:00AM Aurinia Pharmaceuticals Reports Financial Results for the Three Months Ended March 31, 2025
Feb 27, 2025 06:01AM
Feb 27, 2025 06:00AM
Nov 7, 2024 09:08AM
Nov 7, 2024 06:02AM
Nov 7, 2024 06:00AM
Aug 13, 2024 08:00AM
Aug 13, 2024 08:00AM Aurinia Pharmaceuticals Shareholder Calls for CEO Peter Greenleaf, Dr. Brinda Balakrishnan, and Dr. Robert Foster to Resign from the Board
Aug 1, 2024 06:04AM
Aug 1, 2024 06:00AM
May 7, 2024 09:02AM
May 7, 2024 09:00AM
May 2, 2024 06:01AM
May 2, 2024 06:00AM
Feb 15, 2024 06:02AM Aurinia Pharmaceuticals (AUPH) Misses Q4 EPS by 3c, provides guidance
Feb 15, 2024 06:00AM
Nov 2, 2023 06:01AM
Nov 2, 2023 06:00AM
Aug 3, 2023 06:05AM
Aug 3, 2023 06:00AM
Jun 29, 2023 05:23PM
May 5, 2023 11:00AM MKT Capital Issues Statement Regarding Aurinia’s Disappointing First Quarter 2023 Financial Results
May 4, 2023 06:12AM
May 4, 2023 06:00AM
Feb 28, 2023 06:44AM
Feb 28, 2023 06:00AM
Nov 3, 2022 06:00AM
Aug 4, 2022 06:09AM
Aug 4, 2022 06:00AM Aurinia Reports Second Quarter and Six Months 2022 Financial and Operational Results
Jun 8, 2022 09:00PM
Jun 3, 2022 09:00PM
May 29, 2022 09:00PM
May 23, 2022 09:00PM
May 18, 2022 09:00PM
May 13, 2022 09:00PM
May 13, 2022 09:00PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Aurinia, Stronghold, Lilium, and Li-Cycle and Encourages Investors to Contact the Firm
May 10, 2022 06:15AM

1,219,296 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All